当前位置:Public Access >页面
Chinese/English
Safety and efficacy evaluation of immune checkpoint inhibitors in HIV-infected patients with advanced tumors: a real-world retrospective cohort study in China.

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR2400081181

研究题目:

Safety and efficacy evaluation of immune checkpoint inhibitors in HIV-infected patients with advanced tumors: a real-world retrospective cohort study in China.

Study title:

Safety and efficacy evaluation of immune checkpoint inhibitors in HIV-infected patients with advanced tumors: a real-world retrospective cohort study in China.

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

18017500639

电子邮件

Email

qtchenjun@163.com

通讯地址:

上海市漕廊公路2901号

Address:

No.2901 Caolang Highway, Shanghai

邮政编码

Postcode

201508

项目负责人所有单位:

上海市公共卫生临床中心

Institution:

Shanghai Public Health Clinical Center

批准本研究的伦理委员会名称:

上海市公共卫生临床中心伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Public Health Clinica

研究疾病:

艾滋病毒感染合并晚期肿瘤

Study Ailment:

HIV infection with advanced tumor

研究所处阶段:

Study phase:

Post-market

研究类型:

Type of Study:

Diagnostic Accuracy Test

研究团队:

陈军 洪可 陈龙达 候明杰 袁子清 郭永征

Research team:

Chen jun Hongke Chenlongda Hou mingjie Yuan ziqing Guo Yongzheng

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

上海市

市(区县):

上海市

Country/Area:

China

Province:

Shanghai

City:

Shanghai
单位 上海市公共卫生临床中心
Institution Shanghai Public Health Clinical Center

预计起止时间:

Planned Duration:

2024/3/5 0:00:00-2025/12/31 0:00:00